We scored nuclear positivity for ARX in 34 samples (52%), for PDX1 in 21 samples (32%), 3 tumours (5%) showed strong double positivity and 13 (20%) were negative for both TFs (Figs. 2a, b). Here, PDX1 is linked to neoplasm.